Bio-Techne supplements proxy disclosures after shareholder suit, seeks shareholder vote on Sept. 23
Bio-Techne supplemented its proxy statement and disclosed litigation and demand letters tied to the Merck KGaA acquisition while preserving the Sept. 23 shareholder vote.Key Highlights:Original SEC Filing: BIO-TECHNE Corp [ TECH ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain i…